HMSCs as an alternative therapeutic option for asthma with neutrophil mediated inflammation

^*Autor correspondiente de este trabajo

Producción científica: Contribución a una revista › Carta › revisión exhaustiva

3 Citas (Scopus)

Idioma original	Inglés
Número de artículo	72
Publicación	Experimental and Molecular Medicine
Volumen	50
N.º	6
DOI	https://doi.org/10.1038/s12276-018-0072-7
Estado	Publicada - 1 jun. 2018
Publicado de forma externa	Sí

Acceder al documento

@article{d54a87385ca745b5b806b51921a5c418,

title = "HMSCs as an alternative therapeutic option for asthma with neutrophil mediated inflammation",

author = "Cruz, \{Fernanda F.\} and Rocco, \{Patricia R.M.\} and Weiss, \{Daniel J.\}",

year = "2018",

month = jun,

day = "1",

doi = "10.1038/s12276-018-0072-7",

language = "Ingl{\'e}s",

volume = "50",

journal = "Experimental and Molecular Medicine",

issn = "1226-3613",

publisher = "Springer Nature",

number = "6",

}

TY - JOUR

T1 - HMSCs as an alternative therapeutic option for asthma with neutrophil mediated inflammation

AU - Cruz, Fernanda F.

AU - Rocco, Patricia R.M.

AU - Weiss, Daniel J.

PY - 2018/6/1

Y1 - 2018/6/1

UR - https://www.scopus.com/pages/publications/85048267001

U2 - 10.1038/s12276-018-0072-7

DO - 10.1038/s12276-018-0072-7

M3 - Carta

C2 - 29884808

AN - SCOPUS:85048267001

SN - 1226-3613

VL - 50

JO - Experimental and Molecular Medicine

JF - Experimental and Molecular Medicine

IS - 6

M1 - 72

ER -